Investing.com - Abbott Labs (NYSE:ABT) reported third quarter earnings that beat analyst's expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $0.75 on revenue of $7.66B. Analysts polled by Investing.com anticipated EPS of $0.74 on revenue of $7.65B. That compared to EPS of $0.74 on revenue of $6.83B in the same period a year earlier The company had reported EPS of $0.73 on revenue of $7.77B in the previous quarter.
Abbott Labs shares slightly moved -0,48% to trade at $70.61 in pre-market trade following the report.
For the year, Abbott Labs shares are up 21.91%, outperforming the S&P 500 which is up 4.7% year to date.
Abbott Labs follows other major Healthcare sector earnings this month
On Tuesday, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.04B.
Cantel Medical earnings beat analyst's expectations on September 27, with fourth quarter EPS of $0.62 on revenue of $228.85M. Investing.com analysts expected EPS of $0.58 on revenue of $225.98M
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar